Journal: bioRxiv
Article Title: IRE1 drives a homeostatic response to reduced protein influx into the endoplasmic reticulum
doi: 10.64898/2026.03.02.709157
Figure Lengend Snippet: (A) Schematic representation of FKBP-PKR. The homodimerizer is shown in red. The FKBP F36V domain (light blue) is adjoined to the PKR kinase domain (dark blue) by PKR’s unstructured linker. (B) Co-immunoprecipitation of IRE1α and SEC61α in lysates obtained from H4 cells expressing FKBP-PKR and treated with the homodimerizer for 16 hours. (C) Immunoblot of IRE1α phosphorylation (IRE1α-P) and RT-PCR of XBP1 mRNA and 28S ribosomal RNA in lysates obtained from H4 cells expressing FKBP-PKR and treated with the homodimerizer for the indicated times. Loading control: 28S ribosomal RNA. Data are representative of five independent experiments. (D) RT-qPCR of BLOC1S1 and SCARA3 mRNAs in H4 cells expressing FKBP-PKR and treated with the homodimerizer for 16 hours with or without co-treatment with 10 µM of the IRE1 RNase inhibitor 4µ8C. Data: Mean ± SEM of fold changes normalized to the levels in untreated controls (N≥3). (E) Immunoblot of IRE1α phosphorylation (IRE1α-P) and RT-PCR of XBP1 and GFP mRNAs in lysates obtained from H4 cells expressing eIF2α S51D hosted in a construct that also expresses GFP, for the indicated times. GFP mRNA: transfection and loading control. Data are representative of three independent experiments. The ♢ indicates a non-specific band in the immunoblot (top) and * denotes the hybrid XBP1 amplicon in the RT-PCR (bottom). (F) RT-qPCR of BLOC1S1 and SCARA3 mRNAs in H4 cells expressing eIF2α S51D for 16 hours. Data: Mean ± SEM of fold changes normalized to the levels in untreated controls (N = 3). (G) RT-PCR of XBP1 mRNA and 28S ribosomal RNA in H4 cells expressing FKBP-PKR and treated with the homodimerizer for 16 hours with or without co-treatment with 800 nM ISRIB. Data are representative of three independent experiments. (H) RT-qPCR of the expression levels of the BLOC1S1 mRNA in H4 cells expressing FKBP-PKR, treated with the homodimerizer for 16 hours with or without addition of 800 nM ISRIB. Data: Mean ± SEM of fold changes normalized to the respective levels in untreated controls (N = 3). **p-value < 0.01, Student’s t-test. (I) Immunoblots of PERK and ATF4 in lysates obtained from H4 cells expressing FKBP-PKR and treated with the homodimerizer for the indicated times and 5 µg/ml Tm for 4 hours. Actin: loading control. (J) left panel: RT-qPCR of the ATF6 mRNA in H4 cells with CRISPRi-mediated knockdown of ATF6 (sgATF6); right panel: HSPA5 mRNA in H4 cells expressing FKBP-PKR cells under the following conditions: 2.5 µg/ml Tm for 16 hours, 5 nM Ceapin-A7, and homodimerizer treatment for 16 hours, as indicated, or in cells with CRISPRi-mediated knockdown of ATF6 (sgATF6). For the right panel data: Mean ± SEM of fold changes normalized to the levels in untreated controls. **p-value <0.01, Student’s t-test; n.s. - not significant. (K) RT-PCR of XBP1 and GAPDH mRNAs in U-2 OS IRE1α -/- cells expressing FKBP-PKR and mNeonGreen-tagged IRE1α DAB treated with 20 ng/mL Dox for 48 hours, 5 µg/mL Tm for 4 hours as indicated, and the homodimerizer for the indicated times. Data are representative of three independent experiments. The asterisk indicates the hybrid XBP1 amplicon in the RT-PCR.
Article Snippet: 500 μg of supernatant was then incubated overnight, rotating at 4 °C, with 2.5 μg of the anti-IRE1α antibody (Cell Signaling Technology).
Techniques: Immunoprecipitation, Expressing, Western Blot, Phospho-proteomics, Reverse Transcription Polymerase Chain Reaction, Control, Quantitative RT-PCR, Construct, Transfection, Amplification, Knockdown